ERCC6L and invasive breast carcinoma: However, we also observed a significant reduction in ERCC6L promoter methylation levels in BRCA tumors than in normal control tissue (Fig. 9A) and a negative correlation between ERCC6L mRNA levels and methylation status in BRCA patients (Fig. 9B).